
COVID-19 Conversations Podcast: Participation in vaccine trial
UC dean for clinical research discusses his decision to participate, need for diversity in science
In November 2020, less than a year after SARS-CoV-2, the virus that causes COVID-19, was identified, the world received optimistic news about several vaccines that showed efficacy in fighting the disease. The world is now watching in excitement as the first COVID-19 vaccines are being administered in the United Kingdom and the U.S.
Researchers and scientists often receive accolades and awards when research is successful, but although the attention is well-deserved, the essential role of research participants, without whom none of the successes would be possible, should also be recognized and celebrated.
In the podcast series COVID-19 Conversations, hosts talk to three COVID-19 vaccine trial participants, including Brett Kissela, MD, senior associate dean for clinical research at the UC College of Medicine and chief of research services at UC Health.
Brett Kissela, MD, has his blood drawn as part of the clinical trial process. Photo/Colleen Kelley/UC Creative + Brand
In September, Kissela became a participant in the Moderna trial at the university.
In this podcast of the African Alliance, based in South Africa, Kissela discusses why he chose to particpate, his experiences, hopes and fears as well as what he wants others, globally, to know about the research process.
Featured photo of Brett Kissela participating in the Moderna vaccine trial by Colleen Kelley.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
What parvovirus is and why it's on the rise
July 10, 2025
An infectious virus common in children is on the rise in the Tristate. The Cincinnati Health Department is warning of a rise in parvovirus in Hamilton County. The illness can present itself as a rash on the cheeks and is often called “slapped cheek” disease but can present more serious concerns in pregnant women. Kara Markham, MD, professor of obstetrics and gynecology at the University of Cincinnati College of Medicine recently appeared on Cincinnati Edition on WVXU to discuss how parvovirus is transmitted, the risk of serious cases and how to prevent it.
While working 3 a.m. shifts, UC engineer wowed baseball's Big 12
July 10, 2025
UC College of Engineering and Applied Science graduate Kerrington Cross was named an All-American and Big 12 Player of the Year while co-oping in chemical engineering at L'oreal.
UC joins international Phase 1 trial testing CAR-T therapy for MS
July 10, 2025
The University of Cincinnati Gardner Neuroscience Institute is a trial site for a multicenter, international Phase 1 trial testing CAR-T cell therapy for patients with multiple sclerosis.